Chronic lymphocytic leukemia of the B‐cell type CLL) is the most frequent leukemia in the
Western hemisphere. Recent advances in the understanding of the pathogenesis of this …

B-cell chronic lymphocytic leukemia (CLL) is caused by the abnormal accumulation of non-
functional B-cells in peripheral blood and bone marrow. However, the precise aetiology and …

B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely
variable course, and survival rates ranging from months to decades. It is clear that clinical …

A historical review of gains in the body of knowledge on chronic lymphocytic leukaemia
(CLL) reveals a continuous, steady process from the beginning of the century with the …

The chronic lymphatic leukaemia (CLL) world was surprised to find that the disease split so
neatly down the middle into those patients with unmutated immunoglobulin genes who were …

Chronic lymphocytic leukemia (CLL) follows an extremely variable course with survival
ranging from months to decades. Recently, there has been major progress in the …

Chronic lymphocytic leukemia (CLL) has unique epidemiologic, biologic, and clinical
features. The progressively emerging picture leads us to consider that the critical genes for …

Chronic lymphocytic leukemia (CLL) is an indolent B-cell leukemia. While many patients
may not require therapy, some patients will suffer a progressive course and die of their …

A newly discovered heterogeneity has awakened interest in chronic lymphocytic leukemia
(CLL). This has proved to be the key to unlocking the pathophysiology of the condition. A …

In this review, we summarize the morphological features and immunophenotypic profile of
chronic lymphocytic leukemia (CLL) cells, discuss the value of these investigations as front …